Skip to main content
OpenTrials

Clinical trial condition

Gliosarcoma

Explore clinical trials studying Gliosarcoma. Study availability and eligibility vary by location and protocol.

373 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Gliosarcoma trial results

Completed

Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00093613

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +21 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Adult Brain Tumor Consortium Baltimore, Maryland, United States
View Trial Details
Completed

Aflibercept, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma Multiforme, Gliosarcoma, or Other Malignant Glioma

NCT00650923

Conditions
Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, +23 more
Locations
  • University of California at Los Angeles (UCLA ) Los Angeles, California, United States
  • UCSF-Mount Zion San Francisco, California, United States
  • University of California San Francisco Medical Center-Parnassus San Francisco, California, United States
  • Adult Brain Tumor Consortium Baltimore, Maryland, United States
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme

NCT00641706

Conditions
Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, +19 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
  • Penrose-Saint Francis Healthcare Colorado Springs, Colorado, United States
View all 214 locations
View Trial Details
Completed

Dose-Intense Temozolomide in Recurrent Glioblastoma

NCT00657267

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Tufts Medical Center Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details

Related conditions